Private Advisor Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.02M Buy
+55,777
New +$3.11M 0.01% 854
2022
Q1
Sell
-41,781
Closed -$1.93M 2299
2021
Q4
$1.93M Sell
41,781
-1,061
-2% -$50.3K 0.01% 825
2021
Q3
$2.03M Buy
42,842
+14,474
+51% +$719K 0.01% 875
2021
Q2
$1.47M Buy
28,368
+377
+1% +$18.9K 0.01% 877
2021
Q1
$1.41M Buy
27,991
+414
+2% +$22.1K 0.01% 852
2020
Q4
$1.44M Buy
+27,577
New +$1.32M 0.02% 773
2020
Q3
Sell
-1,750
Closed -$75K 3453
2020
Q2
$75K Buy
+1,750
New +$72.3K ﹤0.01% 1879
2018
Q3
Sell
-21,759
Closed -$939K 1657
2018
Q2
$939K Buy
+21,759
New +$914K 0.02% 505
2016
Q1
Sell
-4,506
Closed -$231K 1144
2015
Q4
$231K Buy
4,506
+115
+3% +$5.86K 0.01% 884
2015
Q3
$206K Buy
4,391
+713
+19% +$43K 0.01% 876
2015
Q2
$229K Buy
+3,678
New +$229K 0.01% 892
2014
Q4
Sell
-488
Closed -$26K 1309
2014
Q3
$26K Buy
+488
New +$24.8K ﹤0.01% 1114
2014
Q1
Sell
-64,436
Closed -$2.83M 852
2013
Q4
$2.83M Buy
+64,436
New +$2.68M 0.32% 68

Other funds holding XPH